353,265 Shares in Corteva, Inc. $CTVA Purchased by Arbejdsmarkedets Tillaegspension

Arbejdsmarkedets Tillaegspension acquired a new position in Corteva, Inc. (NYSE:CTVA) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 353,265 shares of the company’s stock, valued at approximately $23,679,000.

Other hedge funds have also recently bought and sold shares of the company. Chilton Capital Management LLC lifted its stake in Corteva by 18.1% in the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock worth $30,119,000 after acquiring an additional 68,380 shares in the last quarter. Drummond Knight Asset Management Pty Ltd purchased a new stake in Corteva in the 4th quarter worth about $25,713,000. Truist Financial Corp lifted its stake in Corteva by 4.5% in the 3rd quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after acquiring an additional 13,910 shares in the last quarter. Alberta Investment Management Corp acquired a new position in Corteva in the 3rd quarter worth about $5,018,000. Finally, Nordea Investment Management AB increased its position in Corteva by 27.4% in the 3rd quarter. Nordea Investment Management AB now owns 75,675 shares of the company’s stock worth $5,103,000 after purchasing an additional 16,261 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Price Performance

Shares of NYSE:CTVA opened at $83.20 on Friday. The business has a 50 day moving average price of $81.03 and a 200 day moving average price of $73.31. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The company has a market cap of $55.64 billion, a price-to-earnings ratio of 48.94, a PEG ratio of 2.56 and a beta of 0.59. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter in the prior year, the company earned $1.13 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.7 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Insider Activity at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.15% of the company’s stock.

Analysts Set New Price Targets

CTVA has been the topic of several research reports. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. UBS Group upped their target price on Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. The Goldman Sachs Group upped their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Mizuho upped their target price on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. Finally, Oppenheimer upped their target price on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Thirteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $88.14.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.